LAURA INGRAHAM (HOST): Relief and reckoning, that's the focus of tonight's Angle. Over the past few weeks, I've heard from some of the smartest medical minds in America about both the nature of this hideous virus and the most promising treatments that are currently under investigation. Because other countries have been dealing with this longer and on a larger scale, some of them are ahead of us on finding the best drug treatments.
On Monday, I told you about two of them, the antimalarial drug chloroquine and its sister, hydroxychloroquine, manufactured by Sanofi labs. Now today the issue was brought up at the White House briefing by our own John Roberts.
INGRAHAM: Well, I'm not sure what she meant by anecdotal. But the renowned French researcher and infectious disease specialist professor Didier Raoult was tasked by the French government to examine possible cures for COVID-19, and yesterday, he described his results as promising. Good news.
In a video posted on the internet, he said that the first batch of 24 COVID-19 patients that he had treated with the drug chloroquine had seen a rapid and effective speeding up of their healing process and a sharp decrease in the amount of time they remain contagious. Yes.
Well, China and South Korea, the countries hardest hit with COVID-19, they've already developed guidelines for physicians who are prescribing the use of chloroquine and hydroxychloroquine as treatment options. It's not just in animals and it's not just in a lab. Chloroquine was chosen after China did several screening rounds of thousands of existing drugs. Chloroquine is undergoing further trials in more than 10 hospitals there now.
Whatever the president has to do, to cut red tape and bring clear treatment options such as this and also preventatives to Americans, he needs to do it, and I bet it's coming soon.